JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HALL, V. E.
Right arrow Articles by WALDMAN, M. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by HALL, V. E.
Right arrow Articles by WALDMAN, M. S.
Journal of Pharmacology And Experimental Therapeutics, Vol. 88, Issue 3, 221-231, 1946
Copyright © 1946 by American Society for Pharmacology and Experimental Therapeutics


TOXICITY OF STABILIZERS FOR CONCENTRATED HUMAN ALBUMIN SOLUTIONS

I. Production of Cardiac Arrhythmias in Cats by Sodium Salts of Caprylic and Related Fatty Acids

V. E. HALL 1 and M. S. WALDMAN 1

1 Department of Physiology, Stanford University, Calif.

The sodium salts of the lower fatty acids (caproic, heptylic, caprylic and capric) in concentrations ten times those recommended for stabilization of concentrated human albumin solutions tend to evoke ectopic ventricular beats (isolated extra-systoles, coupled rhythms and ventricular tachycardias) when given intravenously to cats. The tendency increases with the length of the fatty acid chain.

Potassium salts abolish these arrhythmias as they do the similar ones caused by toxic doses of digitalis. Hemorrhage does not increase the incidence of these cardiac disturbances. The arrhythmias are attributed to an increase in the automatic rhythmicity of ventricular foci. Since the chances of occurrence of the arrhythmia under the conditions of clinical use are vanishingly small, this toxic action of the fatty acids salts is not considered to contraindicate their use in the concentrations which are effective as stabilizers of concentrated albumin solutions.

Submitted on May 13, 1946







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1946 by the American Society for Pharmacology and Experimental Therapeutics.